Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 305

1.

Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study.

Wu X, Li Q, Xin H, Yu A, Zhong M.

Eur J Clin Pharmacol. 2005 Sep;61(8):567-72. Epub 2005 Aug 26.

PMID:
16133554
[PubMed - indexed for MEDLINE]
2.

The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers.

Xin HW, Wu XC, Li Q, Yu AR, Zhong MY, Liu YY.

Methods Find Exp Clin Pharmacol. 2006 Jan-Feb;28(1):25-9.

PMID:
16541194
[PubMed - indexed for MEDLINE]
3.

Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.

Park JW, Siekmeier R, Merz M, Krell B, Harder S, März W, Seidel D, Schüler S, Gross W.

Int J Clin Pharmacol Ther. 2002 Oct;40(10):439-50.

PMID:
12395976
[PubMed - indexed for MEDLINE]
4.

Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.

Gruber SA, Gallichio M, Rosano TG, Kaplan SS, Hughes SE, Urbauer DL, Singh TP, Lempert N, Conti DJ, Stein DS, Drusano G.

J Clin Pharmacol. 1997 Jul;37(7):575-86.

PMID:
9243350
[PubMed - indexed for MEDLINE]
5.

Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients.

Hermann M, Asberg A, Reubsaet JL, Sather S, Berg KJ, Christensen H.

Int J Clin Pharmacol Ther. 2002 Oct;40(10):451-6.

PMID:
12395977
[PubMed - indexed for MEDLINE]
6.

Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients.

Cooney GF, Mochon M, Kaiser B, Dunn SP, Goldsmith B.

Pharmacotherapy. 1995 May-Jun;15(3):353-6.

PMID:
7667170
[PubMed - indexed for MEDLINE]
7.

Unpredictable cyclosporin--fluconazole interaction in renal transplant recipients.

Sud K, Singh B, Krishna VS, Thennarasu K, Kohli HS, Jha V, Gupta KL, Sakhuja V.

Nephrol Dial Transplant. 1999 Jul;14(7):1698-703.

PMID:
10435879
[PubMed - indexed for MEDLINE]
Free Article
9.

Pharmacokinetic interaction between oral cyclosporin and mibefradil in stabilized post-renal-transplant patients.

Spoendlin M, Peters J, Welker H, Bock A, Thiel G.

Nephrol Dial Transplant. 1998 Jul;13(7):1787-91.

PMID:
9681729
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp.

Qiu W, Jiang XH, Liu CX, Ju Y, Jin JX.

Phytother Res. 2009 Nov;23(11):1553-8. doi: 10.1002/ptr.2808.

PMID:
19370549
[PubMed - indexed for MEDLINE]
11.

Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients.

Bistrup C, Nielsen FT, Jeppesen UE, Dieperink H.

Nephrol Dial Transplant. 2001 Feb;16(2):373-7.

PMID:
11158415
[PubMed - indexed for MEDLINE]
Free Article
12.

Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.

Sagedal S, Asberg A, Hartmann A, Bergan S, Berg KJ.

Clin Transplant. 1998 Dec;12(6):553-6.

PMID:
9850449
[PubMed - indexed for MEDLINE]
13.

Pharmacokinetic interactions between microemulsion formulated cyclosporine A and diltiazem in renal transplant recipients.

Asberg A, Christensen H, Hartmann A, Carlson E, Molden E, Berg KJ.

Eur J Clin Pharmacol. 1999 Jul;55(5):383-7.

PMID:
10456488
[PubMed - indexed for MEDLINE]
14.

Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.

Schädeli F, Marti HP, Frey FJ, Uehlinger DE.

Clin Pharmacokinet. 2002;41(1):59-69.

PMID:
11825097
[PubMed - indexed for MEDLINE]
15.

Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.

Wang Y, Wang C, Li J, Wang X, Zhu G, Chen X, Bi H, Huang M.

Eur J Clin Pharmacol. 2009 Mar;65(3):239-47. doi: 10.1007/s00228-008-0577-4. Epub 2008 Oct 21.

PMID:
18936931
[PubMed - indexed for MEDLINE]
16.

Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients.

Qiu XY, Jiao Z, Zhang M, Zhong LJ, Liang HQ, Ma CL, Zhang L, Zhong MK.

Eur J Clin Pharmacol. 2008 Nov;64(11):1069-84. doi: 10.1007/s00228-008-0520-8. Epub 2008 Jul 18.

PMID:
18636247
[PubMed - indexed for MEDLINE]
17.

[Effect of berberin hydrochloride on blood concentration of cyclosporine A in cardiac transplanted recipients].

Huang XS, Yang GF, Pan YC.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Aug;28(8):702-4. Chinese.

PMID:
18928093
[PubMed - indexed for MEDLINE]
18.

Single daily dose administration of cyclosporine in renal transplant recipients.

Halim MA, Said T, Al-Otaibi T, Eleawa S, Al-Maged H, Gawish AE, Nair P, Al-Muzairai I, Nampoory MR, Al-Mousawi M.

Transplant Proc. 2007 May;39(4):1225-7.

PMID:
17524939
[PubMed - indexed for MEDLINE]
19.

C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.

Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suzuki K, Ito E, Waga S.

Clin Nephrol. 2005 Oct;64(4):258-63.

PMID:
16240896
[PubMed - indexed for MEDLINE]
20.

The effect of short-term dipyrone administration on cyclosporin pharmacokinetics.

Caraco Y, Zylber-Katz E, Fridlander M, Admon D, Levy M.

Eur J Clin Pharmacol. 1999 Aug;55(6):475-8.

PMID:
10492062
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk